Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-108016
Filing Date
2025-08-13
Accepted
2025-08-13 16:05:09
Documents
1
Period of Report
2025-08-11

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3515
  Complete submission text file 0000950170-25-108016.txt   4921
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Issuer) CIK: 0001446847 (see all company filings)

EIN.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 SUMMER STREET SUITE 2300 BOSTON MA 02110
Business Address
Gaskins Tammi L (Reporting) CIK: 0002061679 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34620 | Film No.: 251211447